Table 2.
Results of CPH model to determine individual proteins in the training set associated with survival (A) and recurrence (B). “Poor” effect denotes a worse patient prognosis as the protein intensity increases, and likewise, “favorable” denotes a better prognosis as the protein intensity increases.
| m/z | Protein | Effect | P value |
|---|---|---|---|
| A) Test set: survival markers | |||
| 4049 | Poor | 0.021 | |
| 4737 * | TYB-10 * | Poor | 0.023 |
| 4748 * | TYB-4 * | Poor | 0.015 |
| 7045 | Poor | 0.013 | |
| 11,307 | Histone H4 | Favorable | 0.03 |
| 13,778 | Histone H2B | Favorable | 0.018 |
| B) Test set: recurrence markers | |||
| 4283 | Favorable | 0.006 | |
| 12,275 | Cytochrome C | Favorable | 0.01 |
| 16,789 | Calmodulin | Favorable | 0.056 |
*
Indicates protein form observed has a C-terminal truncation.